%D9%85%D9%8A%D8%B1%D9%88%D8%A8%D9%8A%D9%86%D9%85%D9%85%D8%B1%D9%88%D9%BE%D9%86%D9%85Category:MeropenemMeropenemMeropenemMeropenemMeropenem%D9%85%D8%B1%D9%88%D9%BE%D9%86%D9%85MeropeneemiM%C3%A9rop%C3%A9nem%D5%84%D5%A5%D6%80%D5%B8%D5%BA%D5%A5%D5%B6%D5%A5%D5%B4Meropenem%E3%83%A1%E3%83%AD%E3%83%9A%E3%83%8D%E3%83%A0%E0%AC%AE%E0%AD%87%E0%AC%B0%E0%AD%8B%E0%AC%AA%E0%AD%87%E0%AC%A8%E0%AD%87%E0%AC%AEMeropenemMeropenemMeropenem%D0%9C%D0%B5%D1%80%D0%BE%D0%BF%D0%B5%D0%BD%D0%B5%D0%BCMeropenemMeropenemMeropenem%D0%9C%D0%B5%D1%80%D0%BE%D0%BF%D0%B5%D0%BD%D0%B5%D0%BCMeropenemQ421670%E7%BE%8E%E7%BE%85%E5%9F%B9%E5%8D%97
about
The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMCDaptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial PeritonitisMulti-center Clinical Study of Early Antibios of Severe Acute PancreatitisA Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)Efficacy and Pharmacokinetics of Meropenem in Severe Septic PatientsPopulation Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious DiseasessuPAR to Guide Antibiotics in Emergency DepartmentComparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-TazobactamTemocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract InfectionsCSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative BacteriaPharmacokinetics of Meropenem During High-dose CRRTMK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)Conservative Treatment of Acute Appendicitis in ChildrenClinical Trials to Reduce the Risk of Antimicrobial ResistanceCompare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal InfectionsPharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed MeningitisStudy Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal InfectionsErtapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative InfectionsTrial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Meropenem Pharmacokinetics in Spontaneous Bacterial PeritonitisEvaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy VolunteersBolus Versus Continuous Infusion of MeropenemPopulation Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care UnitsA Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated, Adult Patients With Severe Gram-Negative Lower Respiratory Tract InfectionSecond-generation Sequencing Guides the Treatment of Severe PneumoniaCeftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)Bacterial Load Guided Therapy for Severe Bronchiectasis ExacerbationsPipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.GSK2251052 in the Treatment of Complicated Intra-abdominal InfectionsSafety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal InfectionsA Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsPharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis PatientsTrial for the Treatment of Extensively Drug-Resistant Gram-negative BacilliStudy on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by EnterobacteriaceaeThe Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella PneumoniaeMK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
P4844
Meropenem: a review of its use in patients in intensive care.Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.Pharmacokinetic/Pharmacodynamic Analysis of Meropenem for the Treatment of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients by Monte Carlo Simulation.Meropenem selection induced overproduction of the intrinsic carbapenemase as well as phenotype divergence in Acinetobacter baumannii.Meropenem, levofloxacin and linezolid in human plasma of critical care patients: A fast semi-automated micro-extraction by packed sorbent UHPLC-PDA method for their simultaneous determination.Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae.Antimicrobial stewardship program (ASP): an effective implementing technique for the therapy efficiency of meropenem and vancomycin antibiotics in Iranian pediatric patientsRandomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End PointsEfficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injuryMeropenem: evaluation of a new generation carbapenemMonitoring of Piperacillin-Tazobactam and Meropenem Plasmatic Levels in Critical PatientsMeropenem-induced low valproate levels in a cerebral palsy childPoint-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy
P921
Q121041-58E93774-9570-426F-9EE2-33A4927232F6Q17119372-817F7557-B6C8-4F69-9F23-90889C646EE3Q18975220-12A751C5-4D5F-4A3F-8FB2-0517FE1516E1Q18975970-AE0BD3F4-199F-4302-9C51-AD2CD17BEB22Q221668-51925A17-7D64-4E31-B636-1EF45BA6C2B0Q223102-8AFA8AB2-92C5-4CC2-9005-2706700B3A83Q2622199-08E03AA8-CDD9-473C-82D8-08DF3EC68109Q7255052-C67EF2BD-5942-4141-9AD5-201B1026A608
P2176
Q61909510-9285CA43-A39F-4F4E-BE0C-BDB61666051CQ61924812-787AEF74-7CAC-48F4-B58E-43DB5A46697FQ61966163-2167AAFF-0B70-458A-A9FF-BE38F3FED454Q61969960-254A374E-5719-4858-BC10-242D826FE1ABQ61975364-4D44A164-B691-4EAD-A212-93B2EF3E2794Q62025809-82D9E613-C74F-4233-AC4B-900EA01B639EQ62025985-28502018-99FD-4D81-AD75-61D034E6D1F5Q62040591-BDCAA274-07EB-448B-8D56-CD4223CA56C0Q62809434-CB5C7451-C8DD-4CE0-9C9A-BAB0968B2623Q62811153-9DB42580-E907-4D1B-88F9-AEA2AA39F5CEQ62813020-D2F28B7B-8E00-4CBF-98E6-15AE821C4615Q62822358-7FB9F507-38B5-4B7D-8C4B-5165C80CEE15Q63012540-8E1413EE-69B4-4EB4-88BC-E42682306BD2Q63316302-9714E44E-C31E-4681-9F93-460437E31FF6Q63316977-46B882F5-B50E-4E86-9F84-F5F76AB52228Q63318136-A55C27E0-88C3-4D3B-9781-EBA186159F0EQ63319040-3D188A9F-5178-42F3-A0FC-7ED5FB975258Q63321654-ABA51D8F-1F7F-4F1A-927D-2998E5F0EA68Q63338822-C3CFC75F-CD0A-4074-9BA5-9F2FA47060B1Q63339596-AAE09E57-F078-4154-9622-E2ACDBD26F0DQ63395045-06F47E1C-10F1-4E91-A94E-9848E10A88C5Q63397293-4C695BDF-5FD4-4470-9E6D-9153F097A4D9Q63398999-C0B8DD65-718A-4DDD-8B40-89A0A71BCB6CQ63400663-6F77357D-DEFB-480F-A3C9-A44AC3F2E306Q63401107-74287B6D-445D-4095-94AC-2C9F5CD323D6Q63572427-C14508A4-88A0-4474-B3BB-DC3E79ADE6CAQ63577985-D9A7D04E-892C-409D-8E15-A048510FB84AQ63582084-FAAAFDB6-D4A9-4D5F-9FA3-375C50615C46Q63587447-F84C9C64-952D-4358-B88D-5CC09ECA2E8AQ63590795-4B0A0FF8-A4AC-4F98-A658-0BBD10000680Q63598327-A1EFE6C0-C361-42AA-9D0D-A0478F6C401AQ63806659-631A1432-34AC-4737-9F02-CC74B16D627FQ63812055-C3F53B58-0487-4764-B75A-41F0D70F329DQ63830500-B07423C3-5BAE-4688-931B-F4BAB5285BE1Q63833162-7E2DC586-222B-4EB6-A37F-13D946E9779CQ63834745-130F804E-CA9E-46FC-B4FB-57EAD7D45F3BQ63841947-91B979E2-3CAF-49E5-A60D-C93DF09F24E2Q64139504-BBD432E8-6012-4565-856D-0B5A38340FCAQ64139821-03AB2781-6A4C-4BA6-9FBE-D9A540A99147Q64150718-34374A90-C369-4C94-AE31-009447DFDE54
P4844
Q33897244-910A7513-14BB-412E-A51B-F57295E3014DQ34078480-2B79D174-CDC2-4DD3-B2C9-67CF31763673Q38693420-C67C8934-4294-4504-B832-30D2C85B03EFQ38942332-DD963CCE-0F83-4E21-AFCA-7C653236515BQ40266672-1814FCAD-779D-4CAD-9D91-DA60FC9CEDEEQ40432307-385AAAA2-B32E-4E83-A4CA-3B534F4E9890Q46470310-B7420736-F6BA-47E8-8FA8-79EFF3BCD078Q50600508-F68012A2-245E-41C5-9B65-5F5AF415044DQ61806707-DDCA889A-6F70-4445-ADF7-526656805A67Q64089859-DE77DFC7-A4EE-48D1-9317-3269D6EB8682Q64102168-8D78DE56-2E80-4446-A143-A024739607C6Q81605814-F27A763D-4B74-4962-AECF-1AABF8644703Q86252385-7C59B0CA-961A-4BA8-A22E-4F2F7FC8CFE1Q87672666-64902EC0-84FB-4984-B119-42A4EEDAF923Q87930640-8CD354B9-BE9B-4302-834D-3D38BF643663
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Meropeneemi
@fi
Meropenem
@de
Meropenem
@es
Meropenem
@it
Meropenem
@nl
Meropenem
@ro
Meropenem
@sh
Meropenem
@sr
Meropenem
@sv
Meropenem
@vi
type
label
Meropeneemi
@fi
Meropenem
@de
Meropenem
@es
Meropenem
@it
Meropenem
@nl
Meropenem
@ro
Meropenem
@sh
Meropenem
@sr
Meropenem
@sv
Meropenem
@vi
altLabel
(1R,5S,6S)-2-[(3S,5S)-5-DIMETH ...... arbapen-2-em-3-carboxylic acid
@en
(2S,3R,4R)-2-[(1S,2R)-1-carbox ...... o-2H-pyrrole-5-carboxylic acid
@en
(4R,5S,6S)-3-{[(3S,5S)-5-(dime ...... 0]hept-2-ene-2-carboxylic acid
@en
119478-56-7
@fr
96036-03-2
@fr
Antibiotic sm 7338
@en
C17H25N3O5S
@fr
C17H25N3O5S1
@it
ICI-194660
@cy
ICI-194660
@en
prefLabel
Meropeneemi
@fi
Meropenem
@de
Meropenem
@es
Meropenem
@it
Meropenem
@nl
Meropenem
@ro
Meropenem
@sh
Meropenem
@sr
Meropenem
@sv
Meropenem
@vi